The Hooded crane (*Grus monacha*) and White-naped crane (*Grus vipio*) are categorized as vulnerable species on the International Union for Conservation of Nature Red List, with a global population of approximately 15,000 and 7,000, respectively \[[@r9]\]. Annually, from mid-October, approximately 90% of the world's population for Hooded cranes and half of the world's population for White-naped cranes winter on the Izumi plain in Kagoshima prefecture, Japan. This region is an important overwintering area for Hooded and White-naped cranes, and these birds and their habitats are designated special natural treasures of Japan.

Since winter 1996, our laboratory has conducted surveillance of antibiotic-resistant *Escherichia coli* (*E. coli*) and *Salmonella* spp. in migrating wild cranes on the Izumi plain. Although wild cranes are generally unexposed to antibiotics, we identified antibiotic-resistant bacteria in their fecal samples \[[@r12], [@r13], [@r15]\]. We also showed that antibiotic-resistant *E. coli* isolates were more detectable than those of *Salmonella* spp. in wild cranes \[[@r12], [@r13]\]. *E. coli* is generally used as an indicator bacterium for monitoring antibiotic resistance in livestock and wild animals. In the present study, to determine the antibiotic susceptibility of recent bacterial isolates from wild cranes, we investigated the prevalence of antibiotic-resistant *E. coli* in migrating wild cranes during winter 2016 and 2017.

We collected 200 fresh fecal samples from wild cranes wintering on the Izumi plain (32.11°--32.12° N and 130.27°--130.28° E) in November 2016 and 2017, respectively. Sample collections were conducted in the early morning. Each collected sample that was not soaked by environmental water was put into sterile 35 mm petri dish, stored in a cooler box, and brought to our laboratory. Subsequently, the fecal material was suspended in buffered peptone water (Nissui Pharmaceutical Co., Ltd., Tokyo, Japan) and incubated overnight at 37°C. Then, the supernatant was spread on deoxycholate hydrogen sulfide lactose agar plates (Nissui Pharmaceutical Co., Ltd.) and incubated for 24 hr at 37°C. One or two colonies of suspected *E. coli* per sample were picked and subcultured on XM-G agar (Nissui Pharmaceutical Co., Ltd.). Blue-color colonies forming on XM-G agar were identified as *E. coli* according to the manufacture's instruction, and blue/purple- or red/purple-color colonies were tested by matrix-assisted laser desorption ionization time-of-flight mass spectrometry/time-of-flight mass spectrometry (Bruker, Billerica, MA, U.S.A.) to identified as *E. coli*. Isolated bacterial strains with sterile glycerol to the final concentration of 25% were stored at −80°C until analyzed.

Antibiotic susceptibility tests were performed via the agar dilution method to determine the minimum inhibitory concentrations (MICs) according to the Clinical and Laboratory Standards Institute (CLSI) guidelines for 11 antibiotics: oxytetracycline (OTC), ampicillin (ABPC), nalidixic acid (NAL), cefazolin (CEZ), chloramphenicol (CP), colistin (CL), minocycline (MINO), kanamycin (KM), gentamicin (GM), fosfomycin (FOM), and enrofloxacin (ERFX). The antimicrobial breakpoints used as the MIC for the antibiotics were based on the CLSI criteria \[[@r5]\] or a previous study \[[@r14]\].

We recovered 193 and 183 *E. coli* isolates from wild crane feces during winter 2016 and 2017, respectively. *E. coli* isolates resistant to OTC, ABPC, and NAL were identified in 2016 and 2017 samples, and all isolates were susceptible to MINO, KM, ERFX, CP, CEZ, GM, FOM, and CL ([Table 1](#tbl_001){ref-type="table"}Table 1.Antimicrobial resistance of *Escherichia coli* isolated from wild cranes in each ficial yearAntimicrobial agentsBreak point\
(*µ*g/m*l*)No. of resistance (%)20162017Oxytetracycline1621 (10.9)20 (10.9)Ampicillin326 (3.1)8 (4.4)Cefazolin320 (0)0 (0)Nalidixic acid324 (2.1)14 (7.7)Minocycline160 (0)0 (0)Chloramphenicol320 (0)0 (0)Kanamycin640 (0)0 (0)Gentamicin160 (0)0 (0)Fosfomycin2560 (0)0 (0)Colistin160 (0)0 (0)Enrofloxacin20 (0)0 (0)). The prevalence of resistant isolates was 10.9%, 3.1--4.4%, and 2.1--7.7% for OTC, ABPC, and NAL, respectively. Thus, OTC-resistant *E. coli* isolates were the most common. Furthermore, we identified three types of multiple-resistant *E. coli* isolates (resistant to OTC-ABPC-NAL, OTC-ABPC, or OTC-NAL), demonstrating that all of the resistance phenotypes were combined with OTC-resistance ([Table 2](#tbl_002){ref-type="table"}Table 2.Minimum inhibitory concentration (MIC) values in antimicrobial-resistant *Escherichia coli* isolated from wild cranes*E. coli* IDMIC (*µ*g/m*l*)OxytetracyclineAmpicillinNalidixic acid1600432\--16018-64-16022256\--1602464\--1602932\--1603132\--1603332\--16051-128-1605532\--1605732\--1605832\--16068128\--16073128-1281608064\--16092\--1281609664\--1609764\>512-16098128\--16099-64-16101-256-16105128\--1610632\--1614364-641614832\--16163-256-1617532\--16188\--6416197256\--17005\>512128\>51217014\>512\--17019\>512\--17024\>512\--17028\--25617030\--12817054512\--17058512\--17059\>512\--1706732\--17088\--12817091\>512\--17093\--\>51217095\>51251251217102\>512-12817103\>512-12817114\>512256\>51217123\>512-12817124\>512\>512-17128-\>512-17131512512-17136\>512\--17137512\>512\>51217146\>512-25617179-\>512-1718332-6417196\--128- indicate that *E. coli* isolates were susceptibility to each antimicrobial agent.). Since the beginning of the 21st century, tetracycline antibiotics have been the most commonly used in food-producing animals in Japan \[[@r1], [@r2], [@r8], [@r17]\]. Tetracycline resistance was the most frequent type of antibiotic resistance found among *E. coli* isolates in cattle (average resistance rate: 31.4%), pigs (65.5%), and broiler chickens (63.2%) during 2000--2007 \[[@r8]\], and the isolation rates of tetracycline-resistant strains in these animal species have remained stable until recent years \[[@r17]\]. Our surveillance data in 2007 \[[@r13]\], 2016, and 2017 demonstrated that OTC-resistant *E. coli* isolates from wild cranes were also the most frequently detected (15.9% for 2007, 10.9% for 2016 and 2017) among the antibiotics tested. However, the isolation rates of OTC-resistant *E. coli* have remained at low levels compared with that of food-producing animals in Japan. Furthermore, the types of antibiotic-resistant *E. coli* isolates observed in wild cranes in 2016 and 2017 (OTC, ABPC, and NAL) were less than those in 2007 (OTC, ABPC, NAL, MINO, KM, and ERFX). Thus, a low prevalence of antibiotic resistance has been maintained among Hooded and White-naped cranes wintering on the Izumi plain.

Extended-spectrum β-lactamase (ESBL)-producing *E. coli* represent a major problem in human and veterinary medicine \[[@r4]\]. There are several reports of ESBL producing *E. coli* isolates recovered not only from human and domestic animals but also from wild animals, and most ESBL genes are mutant derivatives of the classical TEM beta-lactamases \[[@r6], [@r7], [@r20]\]. In our present study, almost all ABPC-resistant *E. coli* isolates from wild cranes possessed the TEM beta-lactamase gene (data not shown), correlating with the surveillance results from winter 2007 \[[@r13]\]. However, all ABPC-resistant isolates in the present study were susceptible to cefazolin, a second-generation cephalosporin, indicating that colonization by ESBL-producing *E. coli* is yet to be established in wild crane populations.

The overlapping of living areas between wildlife and other animal species, such as human and livestock, leads to a rapid change in the antibiotic resistance of bacteria colonized in wild animals \[[@r3], [@r11]\]. Therefore, several recent Japanese studies have begun to consider the role of wildlife as sentinels for antimicrobial resistance over a decade \[[@r10], [@r16], [@r18], [@r19]\]. Our results demonstrated that antibiotic resistance has remained low in *E. coli.* isolates from wild cranes since 2007, indicating that the surveillance of antibiotic-resistant *E. coli.* isolates from wild cranes wintering on the Izumi plain could be a useful strategy to indicate the natural environmental pollution by antibiotic-resistant bacteria. In addition, a total of 15 strains of *Salmonella* spp. was also recovered from wild crane fecal samples in the present surveillance. Using these bacterial isolates, further molecular analyses including pulsed-field gel electrophoresis may lead to elucidate whether antibiotic-resistant bacteria entered into the Izumi plain accompanied by the migration of wild cranes or not. In the future, continual and comprehensive surveillance of wild cranes should be undertaken to protect these endangered species from pathogenic epidemics.
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